rxstat › Shortages › Hepatitis B Surface Antigen A Virus / Inactivated
Hepatitis B Surface Antigen A Virus / Inactivated (Twinrix Junior, Twinrix) shortage status
No current shortage
Source: Health Canada shortage reports · Updated Sep 17, 2026
Hepatitis B Surface Antigen A Virus / Inactivated has no current shortage reported in Canada. It has been in shortage before; the history is below.
A combined vaccine used to protect against hepatitis A and hepatitis B.
Products affected
0 / 2
Reports on file
12
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
TWINRIX JUNIOR
10MCG
360UNIT · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02237548 · ended Jun 15, 2026 · Delay in shipping of the drug.
Resolved
TWINRIX JUNIOR
360UNIT
10MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02237548 · ended Dec 8, 2022 · Delay in shipping of the drug.
Resolved
TWINRIX
720UNIT
20MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02230578 · ended Mar 24, 2020 · Delay in shipping of the drug.
Resolved
TWINRIX
720UNIT
20MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02230578 · ended Oct 21, 2019 · Disruption of the manufacture of the drug.
Resolved
TWINRIX JUNIOR
360UNIT
10MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02237548 · ended May 10, 2019 · Demand increase for the drug.
Resolved
TWINRIX
720UNIT
20MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02230578 · ended Mar 14, 2019 · Demand increase for the drug.
Resolved
TWINRIX JUNIOR
360UNIT
10MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02237548 · ended Feb 6, 2019 · Demand increase for the drug.
Resolved
TWINRIX
720UNIT
20MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02230578 · ended Jan 17, 2018 · Demand increase for the drug.
Resolved
TWINRIX JUNIOR
360UNIT
10MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02237548 · ended Dec 4, 2017 · Demand increase for the drug.
Resolved
TWINRIX
720UNIT
20MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02230578 · ended Dec 4, 2017 · Delay in shipping of the drug.
Resolved
TWINRIX JUNIOR
360UNIT
10MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02237548 · ended Oct 10, 2017 · Delay in shipping of the drug.
Resolved
TWINRIX
720UNIT
20MCG · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02230578 · ended Jul 10, 2017 · Demand increase for the drug.
What's happening
There are no active shortage reports for Hepatitis B Surface Antigen A Virus / Inactivated. Health Canada has 12 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Hepatitis B Surface Antigen A Virus / Inactivated is classified under “VIRAL VACCINES” (ATC J07BC).
Recent changes
Sep 17, 2026
Shortage resolved
Common questions
What is Hepatitis B Surface Antigen A Virus / Inactivated used for?
A combined vaccine used to protect against hepatitis A and hepatitis B.
When will Hepatitis B Surface Antigen A Virus / Inactivated be back in stock in Canada?
Hepatitis B Surface Antigen A Virus / Inactivated has no active shortage; supply is normal per Health Canada reports.
Why is Hepatitis B Surface Antigen A Virus / Inactivated in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.